Related Experiment Video
Updated: Oct 13, 2025

A New Technique for Quantitative Analysis of Hair Loss in Mice Using Grayscale Analysis
Published on: March 9, 2015
[Expert opinion. Spironolactone: a new twist on an old story]
Ya A Orlova1, Yu L Begrambekova1, A G Plisuk1
1Medical Research and Educational Center of the M. V. Lomonosov Moscow State University, Moscow, Russia Faculty of Fundamental Medicine, Lomonosov Moscow State University, Moscow, Russia.
Abstract:
The article presents recent data on possibilities of a broader use of mineralocorticoid receptor antagonists for existing indications and of expanding indications for the use of this pharmaceutical group in the context of the novel coronavirus infection COVID-19. The authors discussed prospects for expanded detection of aldosteronism using a new diagnostic approach, including an additional evaluation of blood pressure response to spironolactone.
Related Concept Videos
Antihypertensive Drugs: Potassium-Sparing Diuretics
Drug Therapy
Antianxiety Medications
Adrenergic Antagonists: ɑ and β-Receptor Blockers
Antihypertensive Drugs: Thiazide-Class Diuretics
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
Antihypertensive Drugs: Direct Renin Inhibitors

